GlobeNewswire

SignalFx Raises $75 Million to Fuel Demand for its Cloud Monitoring Platform

Share

SAN MATEO, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring and observability for infrastructure, microservices, and applications, today announced it has raised $75 million in Series E funding led by Tiger Global Management with participation from existing investors. The primary equity financing brings total funding raised to $179 million and will accelerate product development and the company’s rapid global expansion.

SignalFx’s growth comes as organizations have increasingly turned to cloud-native technologies such as microservices, containers, Kubernetes and serverless functions to speed their rate of innovation. SignalFx’s annual revenues have increased by a compound annual growth rate of 170 percent since sales began in 2015 as traditional monitoring tools have failed to keep pace with new requirements for speed, scale and automation. According to Gartner, by 2022, more than 75 percent of global organizations will be running containerized applications in production, up from fewer than 30 percent today.

SignalFx’s customer list has grown to include hundreds of market-leading brands in an array of industry verticals and geographies, from ecommerce, retail, transportation, enterprise, and technology to finance, consumer products, and health care. Customers include both high-tech organizations born in the cloud, such as Acquia, Carbon Black, Cloudreach, Freecharge, HubSpot, Kayak, Namely, Rappi, Shutterfly, Square, and Yelp, as well as traditional enterprises investing in digital transformation, such as Amtrak, athenahealth, Lululemon, NBCUniversal, and the Warehouse Group.

“The addition of Tiger Global Management to our team comes at an important time for SignalFx,” said Karthik Rau, CEO, SignalFx. “SignalFx is at an inflection point in its growth as organizations are investing aggressively in their cloud and digital transformation initiatives and reevaluating their systems management and monitoring strategies. The additional capital from this financing allows us to invest even more in our industry-leading products while also extending our go-to-market reach to more organizations around the world.” 

SignalFx pioneered the use of streaming analytics for monitoring cloud infrastructure and applications, building a highly scalable, low latency platform that can process massive amounts of data using advanced data science to accurately identify patterns of behavior and alert on anomalies in seconds. In November the company further increased the technical leadership of its platform by adding Microservices APM™, the industry’s first real-time application performance monitoring solution designed to accelerate the troubleshooting and triaging of microservices-based applications. Microservices APM is powered by a unique NoSample™ architecture that observes every transaction—instead of just a small random sample—and accurately reports on every anomaly.

SignalFx was founded in 2013 by the original developers of Facebook’s metrics-based monitoring solution (ODS), one of the industry’s first DevOps monitoring platforms. During the last two years, the company has expanded its executive bench to include: Chief Operating Officer Mark Cranney, Chief Financial Officer Mark Resnick, Executive Vice President of Engineering Leonid Igolnik, Chief Marketing Officer Tom Butta, and Chief People Officer Laura MacKinnon.

In February, SignalFx announced the opening of a Research and Development Support Office in Krakow, Poland and expanded sales operations throughout EMEA and Australia. Global headcount is now 270 and growing.

About SignalFx

SignalFx, the only real-time cloud monitoring platform for infrastructure, microservices, and applications, collects and analyzes metrics and traces across every component in your cloud environment. Built on a massively scalable streaming architecture, SignalFx applies advanced analytics and data-science-directed troubleshooting to let operators find the root cause of issues in seconds. SignalFx is trusted by leading enterprises across most every industry sector. SignalFx is backed by Andreessen Horowitz, Charles River Ventures, General Catalyst, and Tiger Global Management.

For More Information:

Contact Mike Moeller, (408) 439-4169

*Gartner, Inc., Best Practices for Running Containers and Kubernetes in Production, Arun Chandrasekaran, 25 February 2019.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor20.8.2019 17:45:00 CESTPress release

Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor New patent granted in the United States by the USPTO protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035 This patent strengthens the protection of lanifibranor in the United States Daix (France), August 20, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced that the United States Patent and Trademark Office (USPTO) granted a new patent on August 20, 2019 that protects the use of lanifibranor for the treatment of fibrotic diseases until June 2035. This new patent further strenghens Inventiva’s patent portfolio for lanifibranor, the Company’s lead product candidate, in the United States, which already comprised a New Chemical Entity (NCE) patent and a patent protect

PCI Biotech: Invitation to second quarter and first half 2019 results presentation20.8.2019 15:38:00 CESTPress release

Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 28 August, 08:30am – 09:30am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. The presentation will be held in English and if you wish to attend the presentation, please confirm with an e-mail to post@pcibiotech.com. The presentation will also be a live webcast and can be accessed through www.pcibiotech.com. It will be possible to post questions through the webcast console. The interim report and the presentation will be available on www.newsweb.no and on the company's webpage, www.pcibiotech.com from 07:00am (CEST) on 28 August 2019. For further information, please contact: Ronny Skuggedal, CFO Email: rs@pcibiotech.no Mobile: +47 9400 5757 About PCI Biotech PCI Biotech is a biopharmaceutica

Regarding resignation of member of the Supervisory Board20.8.2019 15:30:00 CESTPress release

We hereby inform that, T. Lukoševičius, a member of Supervisory Board of AB Klaipedos nafta (hereinafter – the Company) 20 August 2019 submitted a notice of resignation of members of Supervisory Board of the Company as of 3 September 2019 (this day is the last day of the mandate). It should be noted that, currently the Supervisory Board of the Company consists of 3 members, 2 of them are independent. After the resignation of T. Lukoševičius, the Ministry of Energy of the Republic of Lithuania will conduct the selection of new member of the Supervisory Board. The Supervisory Board is elected by the General Meeting of Shareholders for 4 years. If individual members of the Supervisory Board are elected, they shall be elected only until the end of the term of office of the current Supervisory Board. Jonas Lenkšas, Chief Financial Officer,+370 694 80594

SERSTECH AB: Boardmember Anna Werntoft resigns from the Board of Serstech20.8.2019 13:40:00 CESTPress release

Anna Werntoft will leave the board of directors effective on the 30th of September. The reason for her resignation is that she enters a new operational position with terms that does not allow external assignments. Serstech wishes Anna all the best in her new position and would like to thank her for her contribution while being on the Serstech Board. The Serstech will consist of three Board members until the vacant position is filled. The search for a replacement has started and will be concluded before the next annual general meeting. For further information, please contact: Stefan Sandor, CEO, Serstech AB tel: +46 739 606067 email: ss@serstech.com Thomas Pileby, Chairman of the Board, Serstech AB tel: +46 702 072643 email: tp@serstech.com Company website: www.serstech.com The information was submitted for publication, through the agency of the contact person set out above at 13:40 CET on August 20, 2019. Certified advisor to Serstech is Västra Hamnen Corporate Finance AB, phone: 040-2